LETTER TO THE EDITOR
Comments on ‘The effectiveness of capacitive and resistive electric transfer therapy for nonspecific chronic low back pain: a systematic review’
 
More details
Hide details
1
Exercise and Rehabilitation Sciences Institute, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andres Bello, Santiago, Chile
 
 
Submission date: 2025-03-31
 
 
Acceptance date: 2025-07-18
 
 
Online publication date: 2026-02-27
 
 
Corresponding author
Hernán Andrés de la Barra Ortiz   

Exercise and Rehabilitation Sciences Institute, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andres Bello, Santiago, Chile
 
 
 
TOPICS
REFERENCES (15)
1.
Ismail S, Usa H, Nidhya K. The effectiveness of capacitive and resistive electric transfer therapy for nonspecific chronic low back pain: a systematic review. Physiother Quart. 2025;33(1):20–6; doi: 10.5114/pq/189653.
 
2.
Farì G, de Sire A, Fallea C, Albano M, Grossi G, Bettoni E, Di Paolo S, Agostini F, Bernetti A, Puntillo F, Mariconda C. Efficacy of radiofrequency as therapy and diagnostic support in the management of musculoskeletal pain: a systematic review and meta-analysis. Diagnostics. 2022;12(3):600; doi 10.3390/diagnostics12030600.
 
3.
Pollet J, Ranica G, Pedersini P, Lazzarini SG, Pancera S, Buraschi R. The efficacy of electromagnetic diathermy for the treatment of musculoskeletal disorders: a systematic review with meta-analysis. J Clin Med. 2023;12(12); doi: 10.3390/jcm12123956.
 
4.
Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH. Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Syst Rev. 2017;6(1):245; doi: 10.1186/s13643-017-0644-y.
 
5.
Rupiński R, Grata-Borkowska U, Drobnik J. A modern approach to the treatment of acute low back pain: a proposal of a new treatment algorithm. Fam Med Prim Care Rev. 2024;26(4):552–5; doi: 10.5114/fmpcr.2024.144928.
 
6.
Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142; doi: 10.1002/14651858.ED000142.
 
7.
Takeshima N, Sozu T, Tajika A, Ogawa Y, Hayasaka Y, Furukawa TA. Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?. BMC Med Res Methodol. 2014;14(1):30; doi: 10.1186/1471-2288-14-30.
 
8.
Andrade C. Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry. 2020;81(5):20f13681; doi: 10.4088/JCP.20f13681.
 
9.
Dettori JR, Norvell DC, Chapman JR. Fixed-effect vs random-effects models for meta-analysis: 3 points to consider. Global Spine J. 2022;12(7):1624–6; doi: 10.1177/21925682221110527.
 
10.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89; doi: 10.1186/s13643-021-01626-4.
 
11.
Bernardo WM. PRISMA statement and PROSPERO. Int Braz J Urol. 2017;43(3):383–4; doi: 10.1590/S1677-5538.IBJU.2017.03.02.
 
12.
Garner P, Hopewell S, Chandler J, MacLehose H, Schü­nemann HJ, Akl EA, Akl EA, Beyene J, Chang S, Churchill R, Dearness K, Guyatt G, Lefebvre C, Liles B, Marshall R, García LM, Mavergames C, Nasser M, Qaseem A, Sam­pson M, Soares-Weiser K, Takwoingi Y, Thabane L, Trivella M, Tugwell P, Welsh E, Wilson EC, Schünemann HJ; Panel for updating guidance for systematic reviews (PUGs). When and how to update systematic reviews: consensus and checklist. BMJ. 2016;354:i3507; doi: 10.1136/bmj.i3507.
 
13.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928; doi: 10.1136/bmj.d5928.
 
14.
Moseley AM, Rahman P, Wells GA, Zadro JR, Sherrington C, Toupin-April K, Brosseau L. Agreement between the Cochrane risk of bias tool and Physiotherapy Evidence Database (PEDro) scale: a meta-epidemiological study of randomized controlled trials of physical therapy interventions. PLOS ONE. 2019;14(9):e0222770; doi: 10.1371/journal.pone.0222770.
 
15.
Gonzalez GZ, Moseley AM, Maher CG, Nascimento DP, Costa LCM, Costa LO. Methodologic quality and statistical reporting of physical therapy randomized controlled trials relevant to musculoskeletal conditions. Arch Phys Med Rehabil. 2018;99(1):129–36; doi: 10.1016/j.apmr.2017.08.485.
 
eISSN:2544-4395
Journals System - logo
Scroll to top